SINGAPORE, Feb. 11, 2025 /PRNewswire/ -- A NEW breast cancer therapy shown to significantly reduce the risk of cancer recurrence and improve disease-free survival in women is now approved for use in ...

Q2 2025 Earnings Conference Call February 7, 2025 10:00 AM ETCompany ParticipantsRichard Wayne - President and Chief ...

At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...

Plus: A new non-opioid painkiller, the wave of lawsuits against Trump EOs, a key vote for RFK Jr., a big radiopharma deal and more.

Here, we explain the facts behind several more of Robert F. Kennedy Jr.’s claims during his two Senate hearings as nominee ...

The U.S. Food and Drug Administration (FDA) has approved this ... An update 2021.” Hematol Oncol. 2021 Jun;39 Suppl 1:46-51. Medline Plus (National Library of Medicine) “Mogamulizumab-kpkc injection.” ...

The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...

GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

Ozempic Approval Expanded to Include T2D Patients ... patients as young as 1 year old experiencing fat malabsorption. FDA Clears Digestive Enzyme Cartridge RELiZORB for Kids as Young as 1 Year ...

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food ...